Inventor · disambiguated record
Shanghai Yu
Also filed as: YU SHANGHAI
16 granted patents·3 pending applications·125 citations·filing 2006–2025
92Inventor score
Files withTERNS INC5JIANGSU HENGRUI MEDICINE CO3UNIV MICHIGAN2WANG SHAOMENG2BRISE PHARMACEUTICALS CO LTD1
Top patents by PatentIndex Score
19 records- 0196US7737174B2Indole inhibitors of MDM2 and the uses thereofUNIV MICHIGAN·Filed 2007·Granted Jun 15, 2010·49 cites·25 claims
- 0295US12365669B2THRβ receptor agonist compound and preparation method and use thereofTERNS INC·Filed 2025·Granted Jul 22, 2025·3 cites·34 claims
- 0395US11034676B2THRB receptor agonist compound and preparation method and use thereofTERNS INC·Filed 2020·Granted Jun 15, 2021·9 cites·29 claims
- 0494US12338232B2THRβ receptor agonist compound and preparation method and use thereofTERNS INC·Filed 2023·Granted Jun 24, 2025·3 cites·25 claims
- 0594US11084802B2THRβ receptor agonist compound and preparation method and use thereofTERNS INC·Filed 2019·Granted Aug 10, 2021·11 cites·17 claims
- 0692US8222288B2Small molecule inhibitors of MDM2 and the uses thereofWANG SHAOMENG·Filed 2010·Granted Jul 17, 2012·28 cites·16 claims
- 0787US8518984B2Spiro-oxindole MDM2 antagonistsWANG SHAOMENG·Filed 2010·Granted Aug 27, 2013·11 cites·37 claims
- 0882US10906905B2Five-membered heteroaryl ring bridged ring derivative, preparation method therefor and medical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2017·Granted Feb 2, 2021·2 cites·20 claims
- 0980US9079913B2Spiro-oxindole MDM2 antagonistsUNIV MICHIGAN·Filed 2014·Granted Jul 14, 2015·3 cites·15 claims
- 1076US12459926B2THRβ receptor agonist compound and preparation method and use thereofTERNS INC·Filed 2025·Granted Nov 4, 2025·0 cites·9 claims
- 1175US8877796B2Spiro-oxindole MDM2 antagonistsUNIV MACHIGAN·Filed 2013·Granted Nov 4, 2014·4 cites·23 claims
- 1265US10087191B2Piperidine derivative and preparation method and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2016·Granted Oct 2, 2018·1 cites·16 claims
- 1364US11345679B2Quaternary lactam compound and pharmaceutical use thereofSHANGHAI MEIYUE BIOTECH DEV CO LTD·Filed 2019·Granted May 31, 2022·1 cites·14 claims
- 1455US11773087B2GLP-1R receptor agonist compound and use thereofSUZHOU VINCENTAGE PHARMA CO LTD·Filed 2023·Granted Oct 3, 2023·0 cites·14 claims
- 1554US2025296922A1Polysubstituted pyrrolidine derivative, preparation method therefor and use thereofSHANGHAI WENNAI THERAPEUTICS CO LTD·Filed 2025·Application pending·0 cites
- 1652US12378268B2Heterocyclic THR-β receptor agonist compound and preparation method and use thereforHEPAGENE THERAPEUTICS HK LTD·Filed 2020·Granted Aug 5, 2025·0 cites·24 claims
- 1746US10385060B2Piperidine derivative and preparation method and pharmaceutical use thereofJIANGSU HENGRUI MEDICINE CO·Filed 2018·Granted Aug 20, 2019·0 cites·17 claims
- 1845US2025353860A1Piperidine carboxamide azaindane derivative, method for preparing same, and use thereofBRISE PHARMACEUTICALS CO LTD·Filed 2023·Application pending·0 cites
- 1935US2007161634A1Compounds as CCR5 antagonistsPEI GANG·Filed 2006·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Shanghai Yu files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →